Helicobacter pyloritherapy: a paradigm shift

Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy forHelicobacter pylorieradication: a phase III, randomised, double-blind study

(2016) Kazunari Murakami et al.   GUT

Role of bismuth in improvingHelicobacter pylorieradication with triple therapy

(2016) Maria Pina Dore et al.   GUT

Rifabutin Containing Triple Therapy and Rifabutin with Bismuth Containing Quadruple Therapy for Third-Line Treatment ofHelicobacter pyloriInfection: Two Pilot Studies

(2016) Antonio Francesco Ciccaglione et al.   HELICOBACTER

Helicobacter pylori Update: Gastric Cancer, Reliable Therapy, and Possible Benefits

(2015) David Y. Graham   GASTROENTEROLOGY

Molecular Approaches to Identify Helicobacter pylori Antimicrobial Resistance

(2015) Francis Mégraud et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

How to Effectively Use Bismuth Quadruple Therapy

(2015) David Y. Graham et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-lineHelicobacter pyloritherapy

(2015) Wei Zhang et al.   GUT

Kyoto global consensus report onHelicobacter pylorigastritis

(2015) Kentaro Sugano et al.   GUT

Editorial - Avoiding UnethicalHelicobacter pyloriClinical Trials: Susceptibility-Based Studies and Probiotics as Adjuvants

(2015) David Y. Graham   HELICOBACTER

Pathogenesis ofHelicobacter pyloriInfection

(2015) Dionyssios N. Sgouras et al.   HELICOBACTER

A Triple and Quadruple Therapy with Doxycycline and Bismuth for First-Line Treatment ofHelicobacter pyloriInfection: A Pilot Study

(2015) Antonio Francesco Ciccaglione et al.   HELICOBACTER

Hp-normogram (normo-graham) for Assessing the Outcome ofH. pyloriTherapy: Effect of Resistance, Duration, and CYP2C19 Genotype

(2015) David Y. Graham   HELICOBACTER

Azithromycin versus Doxycycline for Urogenital Chlamydia trachomatis Infection

(2015) William M. Geisler et al.   NEW ENGLAND JOURNAL OF MEDICINE

Biofilm Formation byHelicobacter pyloriand Its Involvement for Antibiotic Resistance

(2015) Hideo Yonezawa et al.   Biomed Research International

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising TAK-438 (Vonoprazan) Doses in Healthy Male Japanese/non-Japanese Subjects

(2015) Yuuichi Sakurai et al.   Clinical and Translational Gastroenterology

Helicobacter pyloriand Public Health

(2014) Anthony Axon   HELICOBACTER

Rifabutin-based High-dose Proton-pump Inhibitor and Amoxicillin Triple Regimen as the Rescue treatment forHelicobacter pylori

(2014) Hyun Chul Lim et al.   HELICOBACTER

Pathogenesis ofHelicobacter pyloriInfection

(2014) Marina de Bernard et al.   HELICOBACTER

Evidence-based recommendations for successfulHelicobacter pyloritreatment

(2014) Jeng-Yih Wu et al.   Expert Review of Gastroenterology & Hepatology

Rational Helicobacter pylori Therapy: Evidence-Based Medicine Rather Than Medicine-Based Evidence

(2013) David Y. Graham et al.   Clinical Gastroenterology and Hepatology

Eradication of gastric cancer is now both possible and practical

(2013) Akiko Shiotani et al.   SEMINARS IN CANCER BIOLOGY

Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy

(2013) L. Gatta et al.   BMJ-British Medical Journal

Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures

(2012) J. P. Gisbert et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Usefulness of antimicrobial susceptibility in the eradication of Helicobacter pylori

(2012) A. Cosme et al.   CLINICAL MICROBIOLOGY AND INFECTION

Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma

(2012) Zaiming Lu et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial

(2012) Jyh-Ming Liou et al.   LANCET

Furazolidone inHelicobacter pyloritherapy: Misunderstood and often unfairly maligned drug told in a story of French bread

(2012) DavidY Graham et al.   Saudi Journal of Gastroenterology

Review article: rifabutin in the treatment of refractory Helicobacter pylori infection

(2011) J. P. Gisbert et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Helicobacter pylori Therapy Demystified

(2011) David Y. Graham et al.   HELICOBACTER

Helicobacter pylori Eradication Therapy Research: Ethical Issues and Description of Results

(2010) David Y. Graham   Clinical Gastroenterology and Hepatology

Pharmacologic Aspects of Eradication Therapy for Helicobacter pylori Infection

(2010) Takahisa Furuta et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

Helicobacter pylori treatment in the era of increasing antibiotic resistance

(2010) D. Y. Graham et al.   GUT

Sequential Therapy or Triple Therapy for Helicobacter pylori Infection: Systematic Review and Meta-Analysis of Randomized Controlled Trials in Adults and Children

(2009) Luigi Gatta et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

New concepts of resistance in the treatment of Helicobacter pylori infections

(2008) David Y Graham et al.   Nature clinical practice. Gastroenterology & hepatology